The Helicobacter pylori cag pathogenicity island as a determinant of gastric cancer risk

• Published in: Gut microbes Vol. 16; no. 1; p. 2314201
• Main Authors: Tran, Sirena C., Bryant, Kaeli N., Cover, Timothy L.
• Format: Journal Article
• Language: English
• Published: United States Taylor & Francis 31.12.2024; Taylor & Francis Group
• Subjects: Animals; Antigens, Bacterial - genetics; Antigens, Bacterial - metabolism; Bacterial Proteins - metabolism; bacterial secretion system; effector protein; gastric cancer; Gastrointestinal Microbiome; Genomic Islands; Helicobacter Infections - complications; Helicobacter pylori; Helicobacter pylori - genetics; Humans; inflammation; Peptic Ulcer - complications; Review; Stomach Neoplasms; Helicobacter pylori; gastric cancer; inflammation; bacterial secretion system; effector protein
• ISSN: 1949-0976; 1949-0984; 1949-0984
• DOI: 10.1080/19490976.2024.2314201

Helicobacter pylori strains can be broadly classified into two groups based on whether they contain or lack a chromosomal region known as the cag pathogenicity island (cag PAI). Colonization of the human stomach with cag PAI-positive strains is associated with an increased risk of gastric cancer and peptic ulcer disease, compared to colonization with cag PAI-negative strains. The cag PAI encodes a secreted effector protein (CagA) and components of a type IV secretion system (Cag T4SS) that delivers CagA and non-protein substrates into host cells. Animal model experiments indicate that CagA and the Cag T4SS stimulate a gastric mucosal inflammatory response and contribute to the development of gastric cancer. In this review, we discuss recent studies defining structural and functional features of CagA and the Cag T4SS and mechanisms by which H. pylori strains containing the cag PAI promote the development of gastric cancer and peptic ulcer disease.